Editorial: Glycotherapeutics: Design, synthesis, function and biomedical application of agents emerging from glycochemistry and glycobiology
Front Mol Biosci
.
2022 Sep 8:9:1012485.
doi: 10.3389/fmolb.2022.1012485.
eCollection 2022.
Authors
M Osman Sheikh
1
,
Chantelle J Capicciotti
2
,
Stéphanie Olivier-Van Stichelen
3
Affiliations
1
Discovery Science Division, Amicus Therapeutics, Inc., Philadelphia, PA, United States.
2
Departments of Chemistry, Biomedical and Molecular Sciences, and Surgery, Queen's University, Kingston, ON, Canada.
3
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, United States.
PMID:
36158575
PMCID:
PMC9493436
DOI:
10.3389/fmolb.2022.1012485
No abstract available
Keywords:
carbohydrates; chemical biology; glycans; glycoengineering; glycomics.
Publication types
Editorial
Grants and funding
R01 HD104808/HD/NICHD NIH HHS/United States